We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
Cap. Flow
-$2.97B
Cap. Flow %
-3.9%
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$77.3M
2
BX icon
Blackstone
BX
+$53.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$40.8M
4
PLTR icon
Palantir
PLTR
+$34.3M
5
SNOW icon
Snowflake
SNOW
+$24.8M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$163M
3
LIN icon
Linde
LIN
+$133M
4
AMZN icon
Amazon
AMZN
+$94.7M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$82.6M

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Financials 14.16%
3 Healthcare 12.95%
4 Consumer Discretionary 12.06%
5 Communication Services 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BWFG icon
3001
Bankwell Financial Group
BWFG
$536M
-10,432
Closed -$281K
CABA icon
3002
Cabaletta Bio
CABA
$442M
-14,694
Closed -$163K
CASI
3003
DELISTED
CASI Pharmaceuticals
CASI
-7,159
Closed -$172K
CBUS icon
3004
Cibus
CBUS
$147M
-249
Closed -$75K
CDTX
3005
DELISTED
Cidara Therapeutics
CDTX
-1,392
Closed -$74K
CFFI icon
3006
C&F Financial
CFFI
$283M
-5,683
Closed -$252K
CGNT icon
3007
Cognyte Software
CGNT
$675M
-85,928
Closed -$2.39M
CHMG icon
3008
Chemung Financial Corp
CHMG
$399M
-5,722
Closed -$239K
CHMI
3009
Cherry Hill Mortgage Investment Corp
CHMI
$89.6M
-28,625
Closed -$267K
CKPT
3010
DELISTED
Checkpoint Therapeutics
CKPT
-2,820
Closed -$89K
CMCL icon
3011
Caledonia Mining Corp
CMCL
$400M
-12,706
Closed -$182K
CODX
3012
Co-Diagnostics
CODX
$5.56M
-1,047
Closed -$300K
COFS icon
3013
Choiceone Financial
COFS
$511M
-8,419
Closed -$202K
CRBP icon
3014
Corbus Pharmaceuticals
CRBP
$177M
-3,363
Closed -$199K
CWBC
3015
Community West Bancshares
CWBC
$699M
-18,274
Closed -$336K
CWCO icon
3016
Consolidated Water Co
CWCO
$475M
-24,000
Closed -$323K
CYCN icon
3017
Cyclerion Therapeutics
CYCN
$16.6M
-1,708
Closed -$95K
DHX icon
3018
DHI Group
DHX
$181M
-60,106
Closed -$201K
DYAI icon
3019
Dyadic International
DYAI
$35.3M
-16,097
Closed -$88K
EARN
3020
Ellington Residential Mortgage REIT
EARN
$160M
-11,082
Closed -$136K
EML icon
3021
Eastern Company
EML
$147M
-9,032
Closed -$242K
EPM icon
3022
Evolution Petroleum
EPM
$125M
-47,631
Closed -$161K
ESQ icon
3023
Esquire Financial Holdings
ESQ
$1.14B
-9,413
Closed -$215K
ESSA
3024
DELISTED
ESSA Bancorp
ESSA
-15,540
Closed -$249K
ETON icon
3025
Eton Pharmaceutcials
ETON
$1.26B
-10,340
Closed -$76K

Similar funds

RhumbLine Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.

  • RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
  • RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
  • RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
  • RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
  • RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
  • RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.